CARTI Losses Lessen

by Arkansas Business Staff  on Monday, Mar. 5, 2018 12:00 am   2 min read

CARTI spent $53.8 million on oncology drugs in the first six months of its fiscal year. That's $5.2 million more than it budgeted. (Ken West)

The cancer treatment nonprofit reported a net loss before depreciation of $1.5 million for the six-month period that ended Dec. 31 compared with a loss of $2.7 million during the same period in 2016.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.